Show
Sort by
-
- Journal Article
- A1
- open access
Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status
-
- Journal Article
- A1
- open access
Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps : an analysis of randomized clinical trials
-
- Journal Article
- A1
- open access
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis
-
- Journal Article
- A1
- open access
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
-
- Journal Article
- A1
- open access
The unified airway hypothesis : evidence from specific intervention with anti–IL-5 biologic therapy
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis
-
Chronic rhinosinusitis outcome registry (CHRINOSOR) : establishment of an international outcome registry driven by mHealth technology
-
- Journal Article
- A1
- open access
Dupilumab improves health related quality of life : results from the phase 3 SINUS studies
-
- Journal Article
- A1
- open access
Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies
-
- Journal Article
- A1
- open access
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study